Shield Therapeutics Plc (STX.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 12-2022 | 06-2022 | 12-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,594 | 3,414 | 2,916 | 16,354 | 31,281 |
| Inventories | 2,695 | 1,763 | 1,726 | 2,207 | 1,986 |
| Other current assets | 9,812 | 4,531 | 5,606 | 2,393 | 3,178 |
| TOTAL | $26,101 | $12,216 | $10,248 | $23,292 | $36,445 |
| Non-Current Assets | |||||
| PPE Net | 327 | 238 | 372 | 410 | 82 |
| Intangibles | 15,239 | 14,260 | 32,830 | 36,239 | 36,006 |
| TOTAL | $15,566 | $14,498 | $33,203 | $36,649 | $36,088 |
| Total Assets | $41,667 | $26,714 | $43,450 | $59,941 | $72,533 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,080 | 1,741 | 3,829 | 1,769 | 1,773 |
| Other current liabilities | 713 | N/A | 115 | N/A | 156 |
| TOTAL | $8,860 | $12,875 | $3,944 | $4,562 | $1,929 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,705 | 7,271 | N/A | N/A | N/A |
| TOTAL | $5,705 | $7,271 | $0 | $0 | $0 |
| Total Liabilities | $14,565 | $20,146 | $3,944 | $4,562 | $1,929 |
| Shareholders' Equity | |||||
| Common Shares | 13,734 | 4,709 | 3,933 | 4,370 | 4,481 |
| Retained earnings | -213,288 | -177,461 | -142,667 | -143,865 | -131,863 |
| Other shareholders' equity | 53,569 | 38,619 | 39,200 | 40,229 | 39,401 |
| TOTAL | $27,102 | $6,568 | $39,506 | $55,380 | $70,604 |
| Total Liabilities And Equity | $41,667 | $26,714 | $43,450 | $59,941 | $72,533 |